Notable Labs Stock Today

NTBL Stock   0.40  0.01  2.56%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Over 81

 
High
 
Low
Very High
Notable Labs is selling for 0.4 as of the 6th of October 2024. This is a 2.56% up since the beginning of the trading day. The stock's lowest day price was 0.38. Notable Labs has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Notable Labs symbol was changed from VBLT on 17th of October 2023. Equity ratings for Notable Labs are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of July 2024 and ending today, the 6th of October 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
17th of October 2023
Category
Healthcare
Classification
Health Care
Notable Labs is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 9.66 M outstanding shares of which 622 K shares are now shorted by private and institutional investors with about 12.03 trading days to cover. More on Notable Labs

Moving together with Notable Stock

  0.68EBS Emergent BiosolutionsPairCorr

Moving against Notable Stock

  0.67ZTS Zoetis IncPairCorr
  0.65BMY Bristol Myers SquibbPairCorr
  0.62GILD Gilead SciencesPairCorr
  0.49JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.42PAHC Phibro Animal HealthPairCorr
  0.41FHTX Foghorn TherapeuticsPairCorr

Notable Stock Highlights

Older SymbolVBLT
CEO DirectorMD MBA
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Health Care, NASDAQ Composite, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.01510.0159
Notably Down
Slightly volatile
Total Current Liabilities3.7 M2.7 M
Significantly Up
Slightly volatile
Non Current Liabilities Total1.6 M1.7 M
Notably Down
Slightly volatile
Total Assets19.9 M19.5 M
Fairly Up
Slightly volatile
Total Current Assets14.9 M15.5 M
Sufficiently Down
Slightly volatile
Notable Labs can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Notable Labs' financial leverage. It provides some insight into what part of Notable Labs' total assets is financed by creditors.
Liquidity
Notable Labs currently holds 2.05 M in liabilities. Note, when we think about Notable Labs' use of debt, we should always consider it together with its cash and equity.

Depreciation

244,150
Notable Labs (NTBL) is traded on NASDAQ Exchange in USA. It is located in 320 Hatch Drive, Foster City, CA, United States, 94404 and employs 16 people. Notable Labs was previously known as Vascular Biogenics and was traded on NASDAQ Exchange under the symbol VBLT. Notable Labs is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.86 M. Notable Labs conducts business under Biotechnology sector and is part of Health Care industry. The entity has 9.66 M outstanding shares of which 622 K shares are now shorted by private and institutional investors with about 12.03 trading days to cover. Notable Labs generates negative cash flow from operations
Check Notable Labs Probability Of Bankruptcy
Ownership Allocation
Notable Labs holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Check Notable Ownership Details

Notable Labs Historical Income Statement

At this time, Notable Labs' Total Revenue is quite stable compared to the past year. Gross Profit is expected to rise to about 118.7 K this year, although the value of Other Operating Expenses will most likely fall to about 14.6 M. View More Fundamentals

Notable Stock Against Markets

Notable Labs Corporate Management

Kaile ZaggerInterim OfficerProfile
Joseph WagnerChief OfficerProfile
CFE CPAChief OfficerProfile
Glenn MDChief OfficerProfile

Additional Information and Resources on Investing in Notable Stock

When determining whether Notable Labs is a strong investment it is important to analyze Notable Labs' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Notable Labs' future performance. For an informed investment choice regarding Notable Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Notable Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Notable Stock please use our How to buy in Notable Stock guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Notable Labs. If investors know Notable will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Notable Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.09)
Revenue Per Share
0.042
Return On Assets
(1.06)
Return On Equity
(4.64)
The market value of Notable Labs is measured differently than its book value, which is the value of Notable that is recorded on the company's balance sheet. Investors also form their own opinion of Notable Labs' value that differs from its market value or its book value, called intrinsic value, which is Notable Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Notable Labs' market value can be influenced by many factors that don't directly affect Notable Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Notable Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Notable Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Notable Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.